Home NDC 72065-130 Gvoke PFS
Product NDC 72065-130
11-digit product format 720650130
Labeler code 72065
Product ID 72065-130_f1eb1cb9-848c-cdaf-e053-2995a90a9195
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name glucagon injection, solution
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Xeris Pharmaceuticals, Inc.
Application NDA212097
Marketing category NDA
Marketing start 2019-09-10
Marketing end 0000-00-00
Substance GLUCAGON
Active strength 1 mg/.1mL
Pharmacologic classes Antihypoglycemic Agent [EPC], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE]
NDC exclude flag No
Listing certified through 2024-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 72065-130-99 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 72065-130-99 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 72065-130-99 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 72065-130-99 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 72065-130-99 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 72065-130-99 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 72065-130-99 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 72065-130-99 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 72065-130-99 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 72065-130-99 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 72065-130-99 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 72065-130-99 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N212097-001 GVOKE PFS GLUCAGON 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD 2019-09-10 N212097-002 GVOKE PFS GLUCAGON 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 N212097-003 GVOKE HYPOPEN GLUCAGON 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 N212097-004 GVOKE HYPOPEN GLUCAGON 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 N212097-005 GVOKE KIT GLUCAGON 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2021-08-20 N212097-006 GVOKE VIALDX GLUCAGON 1MG/0.2ML (1MG/0.2ML) SOLUTION / INTRAVENOUS RLD 2025-03-14
Orange Book patents# Current patent rows page 1 of 1 · 9 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N212097-001 11590205 2036-04-22 U-2742 Drug product 2023-03-17 N212097-001 9649364 2036-04-22 U-2742 Drug product 2020-02-21 N212097-002 11590205 2036-04-22 U-2742 Drug product 2023-03-17 N212097-002 9649364 2036-04-22 U-2742 Drug product 2020-02-21 N212097-003 11590205 2036-04-22 U-2742 Drug product 2023-03-17 N212097-003 9649364 2036-04-22 U-2742 Drug product 2020-02-21 N212097-004 11590205 2036-04-22 U-2742 Drug product 2023-03-17 N212097-004 9649364 2036-04-22 U-2742 Drug product 2020-02-21 N212097-005 11590205 2036-04-22 U-2742 Drug product 2023-03-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 188 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N212097-001 GVOKE PFS 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD 2019-09-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-002 GVOKE PFS 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-003 GVOKE HYPOPEN 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-004 GVOKE HYPOPEN 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-005 GVOKE KIT 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2021-08-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-006 GVOKE VIALDX 1MG/0.2ML (1MG/0.2ML) SOLUTION / INTRAVENOUS RLD 2025-03-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N212097-001 GVOKE PFS 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD 2019-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-002 GVOKE PFS 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-003 GVOKE HYPOPEN 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-004 GVOKE HYPOPEN 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-005 GVOKE KIT 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2021-08-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-006 GVOKE VIALDX 1MG/0.2ML (1MG/0.2ML) SOLUTION / INTRAVENOUS RLD, RS 2025-03-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-001 GVOKE PFS 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD 2019-09-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-002 GVOKE PFS 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-003 GVOKE HYPOPEN 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-004 GVOKE HYPOPEN 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-005 GVOKE KIT 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2021-08-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-006 GVOKE VIALDX 1MG/0.2ML (1MG/0.2ML) SOLUTION / INTRAVENOUS RLD, RS 2025-03-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N212097-001 GVOKE PFS 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD 2019-09-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-002 GVOKE PFS 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-003 GVOKE HYPOPEN 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-004 GVOKE HYPOPEN 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-005 GVOKE KIT 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2021-08-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-006 GVOKE VIALDX 1MG/0.2ML (1MG/0.2ML) SOLUTION / INTRAVENOUS RLD, RS 2025-03-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212097-001 GVOKE PFS 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD 2019-09-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212097-002 GVOKE PFS 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212097-003 GVOKE HYPOPEN 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212097-004 GVOKE HYPOPEN 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212097-005 GVOKE KIT 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2021-08-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212097-001 GVOKE PFS 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD 2019-09-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212097-002 GVOKE PFS 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212097-003 GVOKE HYPOPEN 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212097-004 GVOKE HYPOPEN 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212097-005 GVOKE KIT 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2021-08-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212097-001 GVOKE PFS 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD 2019-09-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212097-002 GVOKE PFS 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212097-003 GVOKE HYPOPEN 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212097-004 GVOKE HYPOPEN 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2019-09-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212097-005 GVOKE KIT 1MG/0.2ML (1MG/0.2ML) SOLUTION / SUBCUTANEOUS RLD, RS 2021-08-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N212097-001 GVOKE PFS 0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION / SUBCUTANEOUS RLD 2019-09-10 2680178bc6a6…
Observed Orange Book patent history# Patent history page 1 of 7 · 271 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N212097-001 11590205 2036-04-22 U-2742 Drug product 2023-03-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-001 9649364 2036-04-22 U-2742 Drug product 2020-02-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-002 11590205 2036-04-22 U-2742 Drug product 2023-03-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-002 9649364 2036-04-22 U-2742 Drug product 2020-02-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-003 11590205 2036-04-22 U-2742 Drug product 2023-03-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-003 9649364 2036-04-22 U-2742 Drug product 2020-02-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-004 11590205 2036-04-22 U-2742 Drug product 2023-03-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-004 9649364 2036-04-22 U-2742 Drug product 2020-02-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212097-005 11590205 2036-04-22 U-2742 Drug product 2023-03-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N212097-001 11590205 2036-04-22 U-2742 Drug product 2023-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-001 9649364 2036-04-22 U-2742 Drug product 2020-02-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-002 11590205 2036-04-22 U-2742 Drug product 2023-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-002 9649364 2036-04-22 U-2742 Drug product 2020-02-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-003 11590205 2036-04-22 U-2742 Drug product 2023-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-003 9649364 2036-04-22 U-2742 Drug product 2020-02-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-004 11590205 2036-04-22 U-2742 Drug product 2023-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-004 9649364 2036-04-22 U-2742 Drug product 2020-02-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212097-005 11590205 2036-04-22 U-2742 Drug product 2023-03-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-001 11590205 2036-04-22 U-2742 Drug product 2023-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-001 9649364 2036-04-22 U-2742 Drug product 2020-02-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-002 11590205 2036-04-22 U-2742 Drug product 2023-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-002 9649364 2036-04-22 U-2742 Drug product 2020-02-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-003 11590205 2036-04-22 U-2742 Drug product 2023-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-003 9649364 2036-04-22 U-2742 Drug product 2020-02-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-004 11590205 2036-04-22 U-2742 Drug product 2023-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-004 9649364 2036-04-22 U-2742 Drug product 2020-02-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212097-005 11590205 2036-04-22 U-2742 Drug product 2023-03-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N212097-001 11590205 2036-04-22 U-2742 Drug product 2023-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-001 9649364 2036-04-22 U-2742 Drug product 2020-02-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-002 11590205 2036-04-22 U-2742 Drug product 2023-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-002 9649364 2036-04-22 U-2742 Drug product 2020-02-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-003 11590205 2036-04-22 U-2742 Drug product 2023-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-003 9649364 2036-04-22 U-2742 Drug product 2020-02-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-004 11590205 2036-04-22 U-2742 Drug product 2023-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-004 9649364 2036-04-22 U-2742 Drug product 2020-02-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212097-005 11590205 2036-04-22 U-2742 Drug product 2023-03-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212097-001 11590205 2036-04-22 U-2742 Drug product 2023-03-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212097-001 9649364 2036-04-22 U-2742 Drug product 2020-02-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212097-002 11590205 2036-04-22 U-2742 Drug product 2023-03-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212097-002 9649364 2036-04-22 U-2742 Drug product 2020-02-21 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 64 observed states.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72065-130-99 Gvoke PFS0.5 mg Pre-filled Syringe 1 in 1 POUCH INJECTION, SOLUTION 1 20 72065-130-99 Gvoke PFS0.5 mg Pre-filled Syringe 1 in 1 CARTON INJECTION, SOLUTION 1 20
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72065-130 GVOKE HYPOPEN 1 MG AUTO-INJECTOR (GLUCAGON INJECTION, SOLUTION) INJECTION, SOLUTION GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR (GLUCAGON INJECTION, SOLUTION) INJECTION, SOLUTION GVOKE PFS 1 MG PRE-FILLED SYRINGE (GLUCAGON INJECTION, SOLUTION) INJECTION, SOLUTION GVOKE PFS 0.5 MG PRE-FILLED SYRINGE (GLUCAGON INJECTION, SOLUTION) INJECTION, SOLUTION GVOKE KIT VIAL (GLUCAGON INJECTION, SOLUTION) INJECTION, SOLUTION GVOKE KIT (GLUCAGON INJECTION, SOLUTION) INJECTION, SOLUTION [XERIS PHARMACEUTICALS, INC.] 17 Legacy NDC, 2 package rows 20250523_92385737-dbad-98c5-e053-2995a90a2805.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 72065-130-11 72065013011 1 POUCH in 1 CARTON (72065-130-11) > 1 SYRINGE, PLASTIC in 1 POUCH > .1 mL in 1 SYRINGE, PLASTIC 1 pouch 2019-09-10 0000-00-00 No No Current 72065-130-12 72065013012 2 POUCH in 1 CARTON (72065-130-12) > 1 SYRINGE, PLASTIC in 1 POUCH > .1 mL in 1 SYRINGE, PLASTIC 2 pouch 2019-09-10 0000-00-00 No No Current 72065-130-99 72065013099 1 POUCH in 1 CARTON (72065-130-99) > 1 SYRINGE, PLASTIC in 1 POUCH > .1 mL in 1 SYRINGE, PLASTIC 1 pouch 2019-10-28 0000-00-00 Yes No Current